Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization

Diagnostic and Interventional Radiology

Volumn 17, Issue 2, 2011, Pages 177-180

  Gaba, Ron C ^a   Carroll, Jason J ^a   Bui, James T ^a   Carrillo, Tami C ^a   Knuttinen, M Grace ^a   Owens, Charles A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Atrophy; Chemoembolization; Hypertrophy; Liver; Lobectomy

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ADULT; ARTERY CATHETERIZATION; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIVER ATROPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HYPERTROPHY; LIVER LOBECTOMY; LIVER WEIGHT; MALE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; ORGAN SIZE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79956291103     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.3166-09.1     Document Type: Article

References (14)

1. Gaba RC, Lewandowski RJ, Kulik LM, et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 2009; 16:1587-1596.
2. Siddiqi NH, Devlin PM. Radiation lobectomy- a minimally invasive treatment model for liver cancer: case report. J Vasc Intervent Radiol 2009; 20:664-669.
3. Gaba RC, Bui JT, Knuttinen MG, Owens CA. Re: Radiation lobectomy - a minimally invasive treatment model for liver cancer. J Vasc Intervent Radiol 2009; 20:1394-1396; author reply 1396.
4. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655.
5. Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008; 25:92-103.
6. Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol 2008; 25:110-122.
7. Jakobs TF, Saleem R, Atassi B, et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci 2008; 53:2556-2563.
8. Vogl TJ, Balzer JO, Dette K, et al. Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology 1998; 208:217-222.
9. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739.
10. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171.
11. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
12. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JH. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13:S211-S221.
13. Breedis C, Young G. The blood supply of neoplasm of the liver. Am J Pathol 1954; 30:969-985.
14. Zipprich A. Hemodynamics in the isolated cirrhotic liver. J Clin Gastroenterol 2007; 41:S254-S258.